Sandison Taylor 4
4 · Cidara Therapeutics, Inc. · Filed Jan 7, 2022
Insider Transaction Report
Form 4
Sandison Taylor
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-29+15,600→ 256,231 total - Exercise/Conversion
Restricted Stock Unit
2021-12-29−10,000→ 12,500 totalExp: 2027-09-17→ Common Stock (10,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2021-12-29−5,600→ 6,300 totalExp: 2029-01-30→ Common Stock (5,600 underlying)
Footnotes (5)
- [F1]The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
- [F2]Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 19, 2021.
- [F3]Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
- [F4]On September 18, 2017, the Reporting Person was granted restricted stock units totaling 25,000 shares subject to vesting upon the achievement of various milestones.
- [F5]On January 31, 2019, the Reporting Person was granted restricted stock units totaling 14,000 shares subject to vesting upon the achievement of various milestones.